Patents by Inventor Jerneja Opara

Jerneja Opara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists
    Publication number: 20200163882
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor antagonists, e.g. Enzalutamide or ARN-509, as well as to processes for preparing the same. The solid pharmaceutical compositions are useful in the treatment of prostate cancer.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 28, 2020
    Applicant: Lek Pharmaceuticals d.d.
    Inventors: Rok Grahek, Andrija Lebar, Petra Draksler, Bostjan Petek, Jerneja Opara, Klemen Naversnik, Petra Bozic
  • Solid Pharmaceutical Compositions Of Androgen Receptor Antagonists
    Publication number: 20160346207
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor antagonists, e.g. Enzalutamide or ARN-509, as well as to processes for preparing the same. The solid pharmaceutical compositions are useful in the treatment of prostate cancer.
    Type: Application
    Filed: February 4, 2015
    Publication date: December 1, 2016
    Applicant: Lek Pharmaceuticals d.d.
    Inventors: Rok Grahek, Andrija Lebar, Petra Draksler, Bostjan Petek, Jerneja Opara, Klemen Naversnik, Petra Bozic
  • Therapeutic system comprising amoxicillin and clavulanic acid
    Publication number: 20060121106
    Abstract: The present invention relates to a novel therapeutic system suitable for one or twice daily administration of amoxicillin and clavulanic acid. One part of the dosage is provided by at least one immediate release amoxicillin/clavulanic acid pharmaceutical composition, and the other part of the dosage is provided by at least one delayed and sustained release gastroretentive amoxicillin pharmaceutical composition.
    Type: Application
    Filed: February 20, 2004
    Publication date: June 8, 2006
    Inventors: Janez Kerc, Jerneja Opara, Maja Jenko Osel